Does Dr. KARUPPIAH ARUNACHALAM have financial conflicts of interest?

Dr. KARUPPIAH ARUNACHALAM (M.D.,) has received a total of $2,555 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,555 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KARUPPIAH ARUNACHALAM?

According to CMS Open Payments data, Dr. KARUPPIAH ARUNACHALAM received funding from ABBOTT LABORATORIES ($1,153), HEARTFLOW ($667), and NOVARTIS PHARMACEUTICALS CORPORATION ($192).

Does Dr. KARUPPIAH ARUNACHALAM receive research grants or speaking fees?

Dr. KARUPPIAH ARUNACHALAM has received $2,555 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KARUPPIAH ARUNACHALAM

M.D.,Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: ORLANDO, FL 32806

NPI Number: 1780930719

LIFETIME INDUSTRY VALUE

$2,555

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ARUNACHALAM is a verified Internal Medicine, Cardiovascular Disease practitioner based in ORLANDO, FL.

Between 2021 and 2025, Dr. ARUNACHALAM had an overall industry promotional and research financial footprint of $2,555 as recorded in the federal CMS Open Payments database.

$2,555 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARUNACHALAM's primary funding source is ABBOTT LABORATORIES, which accounts for $1,153 (representing 45.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBOTT LABORATORIES

Rank 1

$1,153

45.1%

HEARTFLOW

Rank 2

$667

26.1%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$192

7.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.